India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,009 Gautam Daftary & family ₹2,700 Cr
Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Active Private Limited Company pharma
Revenue · FY 2025
₹34,420
▼ 33.33% YoY
Net loss · FY 2025
₹3.31 Cr
Latest filing
EBITDA · FY 2025
-₹3.31 Cr
Latest filing
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.02 Lakh
Issued & subscribed
Company age
31 yrs
Est. 1995
Employees · EPFO
2
Provident fund records
Directors on board
2
As per MCA filings
About Aksigen Pharmaceuticals Private Limited
Data last updated:
Aksigen Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 August 1995 and has been in existence for over 31 years.
Its director Gautam Daftary and family are #1,009 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1995PTC091631. Its GSTIN is 27AADCA9664J1Z8 (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.02 Lakh. It was formerly known as Aksign Finvest Private Limited. It is led by directors Siddharth Bharat Daftary and Gautam Vinod Daftary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17th Floor Hoechst House Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹34,420. For the same year it recorded a net loss of ₹3.31 Cr and EBITDA of -₹3.31 Cr. Revenue has declined at a compounded annual rate (CAGR) of 65% over three years and 30% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239MH1995PTC091631
Registration Number 091631
Incorporation Date 09 August 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Recognitions & Rankings of Aksigen Pharmaceuticals
Contact details
Aksigen Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address17th Floor Hoechst House Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aksigen Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Aksigen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Aksigen Pharmaceuticals Private Limited
FY 2025 filings availableAksigen Pharmaceuticals Private Limited reported revenue of ₹34,420 for FY 2025.
Revenue · FY 2025
₹34,420
Net loss · FY 2025
₹3.31 Cr
EBITDA · FY 2025
-₹3.31 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▼ 65%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▼ 143%
3 years · compounded
▼ 103%
5 years · compounded
▼ 94%
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years. EBITDA fell 143% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.31 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aksigen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Bharat Daftary Also directs: Hitech Laboratories Private Limited, Genei Laboratories Private Limited, Rivaara Labs Private Limited and 5 more | Director | 07 Dec 2023 | 2 Years 10 Months | Current |
| Gautam Vinod Daftary Also directs: Iravata Retail Enterprises LLP, Palettier Retail Private Limited, Hitech Laboratories Private Limited and 5 more | Director | 09 Aug 2005 | 21 Years 2 Months | Current |
Auditor
Aksigen Pharmaceuticals Private Limited is audited by Vinay Sanjay & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vinay Sanjay & Associates | FY 2022 | 112195W |
Shareholding
The shareholding of Aksigen Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aksigen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aksigen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aksigen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aksigen Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
2
Active EPFO establishments
1
GST
Aksigen Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCA9664J1Z8 | Maharashtra | Active | 29 Apr 2023 |
To see the full GST registrations and return filing status of Aksigen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aksigen Pharmaceuticals Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Siddharth Bharat Daftary ceased to be Additional Director on 29 Sep 2024.
AGM
Aksigen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aksigen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Siddharth Bharat Daftary ceased to be Additional Director.
Ceased
Bharat Vinod Daftary ceased to be Director.
Appointed
Siddharth Bharat Daftary was appointed as Director.
Appointed
Gautam Vinod Daftary was appointed as Director.
Incorporation
09 Aug 1995
Aksigen Pharmaceuticals Private Limited was registered on 09 Aug 1995 with Roc Mumbai I & aged 31 years 2 months as per MCA records.
Frequently asked questions
Aksigen Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 August 1995 (31+ years old) and is registered under CIN U24239MH1995PTC091631.
Aksigen Pharmaceuticals has 2 current directors:
- Siddharth Bharat Daftary - Director
- Gautam Vinod Daftary - Director
The latest financial statements of Aksigen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aksigen Pharmaceuticals is 27AADCA9664J1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aksigen Pharmaceuticals is U24239MH1995PTC091631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aksigen Pharmaceuticals was incorporated on 09 August 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Siddharth Bharat Daftary ceased to be Additional Director on 29 Sep 2024. Bharat Vinod Daftary ceased to be Director on 07 Dec 2023. Siddharth Bharat Daftary was appointed as Director on 07 Dec 2023. Aksigen Pharmaceuticals has 4 board changes on record in total.
The registered office of Aksigen Pharmaceuticals is at 17th Floor Hoechst House Nariman Point, Mumbai, Maharashtra, India – 400021.
Aksigen Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Aksigen Pharmaceuticals is compliant as of 04 August 2026. The company is actively filing with the Registrar of Companies.